NOT KNOWN FACTUAL STATEMENTS ABOUT MBL77

While reduced-depend MBL not often progresses to CLL, significant-depend MBL progresses to CLL necessitating therapy in a price of 1% to 2% per annum. Higher-rely MBL is distinguished from Rai 0 CLL depending on whether or not the B-cell count is higher than or under 5 × 109/L. Though people with equally large-rely MBL and CLL Rai stage 0 are at e